H1B Salary Data

Home › Employers › Korber Pharma Inc

Korber Pharma Inc: H-1B salaries and sponsorship

Korber Pharma Inc filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $109,500.

Applications (LCAs)4
Certified4
Employer addressFargo, ND
H-1B dependent employerNo
Median offered salary$109,500
Middle half of salaries$81,856–$135,000
10th–90th percentile$68,997–$144,000

Does Korber Pharma Inc sponsor H-1B visas?

Korber Pharma Inc filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on May 14, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Senior Consultant2$140,000
Systems Administrator1$60,424
Software Engineer1$89,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20232$95,212
FY20251$150,000
FY20261$89,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Software Engineer$89,000–$93,000
Level II
Fargo, NDMay 14, 2026Oct 1, 2026Certified
Senior Consultant$150,000–$155,000
Level IV
Naples, FLMar 20, 2025Apr 17, 2025Certified
Systems Administrator$60,424–$70,000
Level I
Fargo, NDSep 19, 2023Oct 1, 2023Certified
Senior Consultant$130,000–$138,000
Level III
Naples, FLMay 22, 2023Oct 1, 2023Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).